Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 12

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01226316Phase 1Completed
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Advanced or Metastatic Breast CancerAdvanced Solid MalignancyAKT1+11 more
PrincipalinvestigatorStart date: 2010-12-01
NCT01895946Phase 1Completed
Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability
Advanced Solid Malignancy,Pharmacokinetics, Pharmacodynamics,Safety and Tolerability,+1 more
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Gaia Schiavon, MSD

AstraZeneca

Very Similar
1 trials

Shared therapeutic areas:

Advanced or Metastatic Breast CancerAdvanced Solid MalignancyAKT1+11 more

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score144%

Justin Lindemann, MSD

AstraZeneca

Moderately Similar
1 trials

Shared therapeutic areas:

Advanced Solid MalignancyPharmacokinetics, Pharmacodynamics,Safety and Tolerability+1 more

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score44%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial CarcinomaOvary Cancer
Similarity Score6%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Ovary CancerCancer of the Uterine CervixEndometrial Carcinoma
Similarity Score6%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial CarcinomaOvary Cancer
Similarity Score6%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine CervixOvary Cancer
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Ovary CancerCancer of the Uterine Cervix
Similarity Score4%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of the Uterine CervixOvary Cancer
Similarity Score4%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score2%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01226316Phase 1PrincipalInvestigator

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Advanced or Metastatic Breast CancerAdvanced Solid MalignancyAKT1+11 more
Completed
NCT01895946Phase 1PrincipalInvestigator

Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability

Advanced Solid Malignancy,Pharmacokinetics, Pharmacodynamics,Safety and Tolerability,+1 more
Completed

All 2 trials loaded